Explore

Deep-tech startup’s most technically ready market may still be wrong to enter first.

If another market has stronger urgency, margins & adoption economics, extra R&D can be the rational choice.

Weren't able to tune into our recent webinar on #intellectualproperty, #technology ecosystems, and #commercialization?

📽️ Watch the recording here:

B&C's Biobased Policy News: Bipartisan House Bill Would Direct Secretary of Commerce to Develop Prioritized Action Plan for Biomanufacturing
www.lawbc.com/bipartisan-h...
#biomanufacturing, #commercialization, #FDA, #EPA

Korean public research institutions held 426,395 technologies in 2024, but recorded just 9,306 transfers. 🔬➡️🏭

The commercialization problem may be the handoffs between programs, capital and industry.

You built the prototype. Now decide what role you want to play in bringing it to market.

🏢 Build a business
🤝 Explore licensing
🔗 Consider partnerships

If licensing is on the table, research matters.

Did you know pharma commercialization has been stuck in the past? Trinity is ditching historical analysis, using AI to run predictive simulations for